Clinical trials
Carcinoma, Non-Small-Cell Lung trials in Israel
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
202 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 3 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 4 |
| 2006 | 6 |
| 2007 | 6 |
| 2008 | 2 |
| 2009 | 5 |
| 2010 | 4 |
| 2011 | 4 |
| 2012 | 6 |
| 2013 | 5 |
| 2014 | 7 |
| 2015 | 9 |
| 2016 | 7 |
| 2017 | 10 |
| 2018 | 11 |
| 2019 | 12 |
| 2020 | 18 |
| 2021 | 16 |
| 2022 | 13 |
| 2023 | 12 |
| 2024 | 13 |
| 2025 | 17 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 77 |
| Recruiting | 43 |
| Active, not recruiting | 42 |
| Terminated | 24 |
| Unknown status | 10 |
| Not yet recruiting | 2 |
| Withdrawn | 1 |
| Suspended | 1 |
| No longer available | 1 |
| Approved for marketing | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 23 |
| AbbVie | 18 |
| Eli Lilly and Company | 13 |
| AstraZeneca | 12 |
| Novartis Pharmaceuticals | 12 |
| Hoffmann-La Roche | 11 |
| Pfizer | 9 |
| Janssen Research & Development, LLC | 7 |
| Boehringer Ingelheim | 5 |
| Bayer | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 202 |
| Lung Neoplasms | 31 |
| Neoplasms | 24 |
| Melanoma | 18 |
| Neoplasm Metastasis | 16 |
| Colorectal Neoplasms | 12 |
| Triple Negative Breast Neoplasms | 11 |
| Breast Neoplasms | 10 |
| Adenocarcinoma of Lung | 9 |
| Carcinoma, Renal Cell | 9 |
Trials
Showing 26 to 50 of 202. Each trial links to its page on Pharma Observatory.
102 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.